Trial Profile
A study of AAV-S100A1 gene therapy in cardiovascular disorders
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 01 Jun 2015
Price :
$35
*
At a glance
- Drugs AAV S100A1 (Primary)
- Indications Cardiovascular disorders
- Focus Adverse reactions
- 01 Jun 2015 New trial record